Study of Safety and Proof of the Mechanism of BLZ945 in ALS Patients
Clinical trial NCT04066244 · TERMINATED
Trial details
- NCT number
- NCT04066244
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-30
- Primary completion
- 2024-02-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.